SIBN — SI-BONE, Inc.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1459839 ·
Last close
$19.47
Market Cap
$863.48M
52W High
$20.28
52W Low
$13.41
ADV30
520,844
Next earnings
2026-08-03
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 56,010,000 44,548,000 -4,806,000 -4,088,000 248,758,000 33,128,000 66,411,000
Mar 2026 52,588,000 41,944,000 -5,093,000 -4,334,000 242,718,000 33,535,000 63,776,000
Dec 2025 56,349,000 44,531,000 -2,463,000 -1,644,000 238,555,000 42,240,000 61,023,000
Sep 2025 48,656,000 38,846,000 -5,383,000 -4,566,000 234,273,000 26,487,000 62,147,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,478,000
Investing CF
$-5,969,000
Financing CF
$2,702,000
CapEx
$-6,865,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.34
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-458,680,000
Inventory
$38,389,000
Receivables
$31,180,000
ST Investments
$112,813,000
EBIT TTM
$-12,142,000
Pretax Income TTM
$-14,632,000
Interest Exp TTM
$2,490,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$213,603,008
EBITDA
$-11,325,000
Free Cash Flow
$-861,875
Enterprise Value
$769,471,680
Total Cash
$145,940,992
Total Debt
$42,795,000
Shares Out
44,349,283
Trailing EPS
$-0.33
Book Value
$4.08
ROE
-8.3%
ROA
-4.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 200,925,000 -22,330,000 -18,904,000 238,555,000 61,023,000 -675,000
Dec 2024 167,178,000 -35,248,000 -30,913,000 230,437,000 63,473,000 -12,425,000
Dec 2023 138,886,000 -46,931,000 -43,336,000 230,425,000 61,050,000 -18,713,000
Dec 2022 106,409,000 -59,609,000 -61,256,000 157,552,000 59,250,000 -41,655,000

TTM Snapshot

Revenues TTM
$123,072,000
NetIncome TTM
$-46,627,000
OpCashFlow TTM
$0
Assets (Latest)
$230,437,000
Forward EPS
$-0.33

Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $15.00 · spot: $19.59 · call volume: 1,055 · put volume: 1,913

Peers — same industry

TickerNameMarket CapLastDaily %
INMD InMode Ltd. $868.92M $15.10
AVR Anteris Technologies Global Corp. $856.61M $8.80
SGP SpyGlass Pharma, Inc. $878.34M $26.26
BBNX Beta Bionics, Inc. $887.65M $19.73
CBLL Ceribell, Inc. $918.77M $23.94

News headlines (Yahoo Finance, 1h cache)

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
2026-08-25 16:00 · Yahoo
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
2026-08-11 01:29 · Yahoo
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
2026-08-06 13:55 · Yahoo
SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
2026-08-04 05:07 · Yahoo
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
2026-08-03 22:45 · Yahoo
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
2026-08-03 20:09 · Yahoo
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
2026-07-20 20:09 · Yahoo
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
2026-06-03 13:55 · Yahoo
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
2026-06-01 13:55 · Yahoo
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
2026-05-15 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.